Clinical Trial Update: BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of BMS-188797 with carboplatin in adults with advanced nonhematologic solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BMS-188797
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED